Literature DB >> 11721161

Hospitalizations for fungal infections after initiation of chronic dialysis in the United States.

K C Abbott1, I Hypolite, D J Tveit, P Hshieh, D Cruess, L Y Agodoa.   

Abstract

AIMS: Hospitalized fungal infections are reported frequently in renal transplant recipients and peritoneal dialysis patients, but the frequency of hospitalized fungal infections in dialysis patients has not been studied in a national population.
METHODS: 327,993 dialysis patients in the United States Renal Data System initiated from January 1, 1992 to June 30, 1997 were analyzed in a retrospective registry study of fungal infections (based on ICD9 Coding).
RESULTS: Dialysis patients had an age-adjusted incidence ratio for fungal infections of 9.80 (95% confidence interval (CI) 6.34-15.25)) compared to the general population in 1996 (the National Hospital Discharge Survey). Candidiasis accounted for 79% of all fungal infections, followed by cryptococcosis (6.0%) and coccidioidomycosis (4.1%). In multivariate analysis, fungal infections were associated with earlier year of dialysis, diabetes, female gender, decreased weight and serum creatinine at initiation of dialysis, chronic obstructive lung disease and AIDS. In Cox regression analysis the hazard ratio for mortality of fungal infections was 1.35 (95% CI 1.28-1.42).
CONCLUSIONS: Dialysis patients were at increased risk for fungal infections compared to the general population, which substantially decreased patient survival. Female and diabetic patients were at increased risk for fungal infections. Although candidiasis was the dominant etiology of fungal infections, the frequency of cryptococcosis and coccidioidomycosis were higher than previously reported. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2001        PMID: 11721161     DOI: 10.1159/000046115

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  6 in total

1.  Paradoxical cryptococcal immune reconstitution inflammatory syndrome in advanced chronic kidney disease.

Authors:  Chih-Chin Kao; Vin-Cent Wu; Hsin-Yun Sun; Che-Hsiung Wu
Journal:  Int Urol Nephrol       Date:  2012-05-25       Impact factor: 2.370

Review 2.  Diabetes and kidney transplantation: past, present, and future.

Authors:  Giselle Guerra; Amna Ilahe; Gaetano Ciancio
Journal:  Curr Diab Rep       Date:  2012-10       Impact factor: 4.810

3.  Predictors and outcomes of peritoneal dialysis-related infections due to filamentous molds (MycoPDICS).

Authors:  Talerngsak Kanjanabuch; Tanawin Nopsopon; Tanittha Chatsuwan; Sirirat Purisinsith; David W Johnson; Nibondh Udomsantisuk; Guttiga Halue; Pichet Lorvinitnun; Pongpratch Puapatanakul; Krit Pongpirul; Ussanee Poonvivatchaikarn; Sajja Tatiyanupanwong; Saowalak Chowpontong; Rutchanee Chieochanthanakij; Oranan Thamvichitkul; Worapot Treamtrakanpon; Wadsamon Saikong; Uraiwan Parinyasiri; Piyatida Chuengsaman; Phongsak Dandecha; Jeffrey Perl; Kriang Tungsanga; Somchai Eiam-Ong; Suchai Sritippayawan; Surasak Kantachuvesiri
Journal:  PLoS One       Date:  2022-05-24       Impact factor: 3.752

4.  Comparative effectiveness studies to improve clinical outcomes in end stage renal disease: the DEcIDE patient outcomes in end stage renal disease study.

Authors:  L Ebony Boulware; Navdeep Tangri; Patti L Ephraim; Julia J Scialla; Stephen M Sozio; Deidra C Crews; Tariq Shafi; Dana C Miskulin; Jiannong Liu; Wendy St Peter; Bernard G Jaar; Albert W Wu; Neil R Powe; Sankar D Navaneethan; Karen Bandeen-Roche
Journal:  BMC Nephrol       Date:  2012-12-06       Impact factor: 2.388

5.  Cryptococcosis in HIV-negative Patients with Renal Dialysis: A Retrospective Analysis of Pooled Cases.

Authors:  Nan Hong; Min Chen; Wenjie Fang; Abdullah M S Al-Hatmi; Teun Boekhout; Jianping Xu; Lei Zhang; Jia Liu; Weihua Pan; Wanqing Liao
Journal:  Mycopathologia       Date:  2017-06-30       Impact factor: 2.574

6.  Histoplasma Peritonitis: An Extremely Rare Complication of Peritoneal Dialysis.

Authors:  Asjad Sardar; Bijin Thajudeen; Pradeep V Kadambi
Journal:  Case Rep Nephrol       Date:  2018-05-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.